Stock Fundamentals

Company Information

Company Name
Fennec Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA31447P1009
CIK: 0001211583
CUSIP: 00686R408
Currency: USD
Full Time Employees: 35
Phone: 919 636 4530
Fiscal Year End: December
IPO Date: Jun 05, 2001
Description:

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Address:

68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709

Directors & Officers

Name Title Year Born
Mr. Jeffrey S. Hackman CEO & Director 1963
Mr. Robert C. Andrade Chief Financial Officer 1975
Dr. Pierre S. Sayad M.S., Ph.D. Chief Medical Officer NA
Mr. Terry Evans Chief Commercial Officer NA
Ms. Christiana Cioffi M.B.A. Chief Strategy Officer NA
Mr. Mark Gowland Controller NA
Mr. Lei Fang President of Pharstat Inc NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 01, 2026 Rosty Raykov N/A Sale 10.95K $6.31 $69.07K
Feb 02, 2026 Rosty Raykov N/A Sale 10.35K $7.76 $80.31K
Dec 24, 2025 Southpoint Capital Advisors Lp N/A Sale 1.00M $7.50 $7.50M
Dec 05, 2025 Rosty Raykov N/A Sale 10.00K $7.54 $75.40K
Nov 18, 2025 Southpoint Capital Advisors Lp N/A Sale 19.34K $8.79 $170.01K
Nov 17, 2025 Southpoint Capital Advisors Lp N/A Sale 85.92K $8.79 $755.22K
Nov 14, 2025 Southpoint Capital Advisors Lp N/A Sale 160.10K $8.00 $1.28M
Nov 05, 2025 Rosty Raykov N/A Sale 10.00K $8.10 $81.00K
Oct 10, 2025 Chris A Rallis N/A Sale 1.78K $9.24 $16.40K
Oct 09, 2025 Southpoint Capital Advisors Lp N/A Sale 20.61K $9.35 $192.69K
Oct 08, 2025 Southpoint Capital Advisors Lp N/A Sale 19.61K $9.47 $185.66K
Oct 07, 2025 Southpoint Capital Advisors Lp N/A Sale 26.90K $9.59 $257.97K
Oct 06, 2025 Rosty Raykov N/A Sale 10.00K $9.78 $97.80K
Aug 05, 2025 Rosty Raykov N/A Sale 10.00K $8.09 $80.90K
Jul 07, 2025 Chris A Rallis N/A Sale 1.12K $8.71 $9.75K
Jul 03, 2025 Rosty Raykov N/A Sale 10.00K $8.61 $86.10K
Jun 05, 2025 Rosty Raykov N/A Sale 10.00K $7.78 $77.80K
May 19, 2025 Jeffrey S Hackman N/A Purchase 13.97K $6.99 $97.62K
May 16, 2025 Jeffrey S Hackman N/A Purchase 1.04K $6.75 $6.99K
May 05, 2025 Rosty Raykov N/A Sale 10.00K $6.31 $63.10K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Rosalind Advisors, Inc. 2.91M Mar 31, 2026 8.37% $7.19 11.28%
Southpoint Capital Advisors LP 2.74M Mar 31, 2026 7.90% $0.35 0.00%
Solas Capital Management LLC 2.48M Mar 31, 2026 7.15% $8.78 -3.07%
AIGH Capital Management, LLC 1.98M Mar 31, 2026 5.70% $1.66 25.29%
BlackRock Inc 1.37M Mar 31, 2026 3.94% $0.00 10.85%
Vanguard Group Inc 1.07M Dec 31, 2025 3.07% $0.00 11.71%
Vanguard Capital Management, LLC 897.14K Mar 31, 2026 2.58% $0.00 0.00%
Awm Investment Company Inc 720.14K Mar 31, 2026 2.07% $0.49 1.16%
Geode Capital Management, LLC 371.74K Mar 31, 2026 1.07% $0.00 25.12%
State Street Corp 359.06K Mar 31, 2026 1.03% $0.00 1.78%
Potomac Capital Management, Inc. 224.40K Mar 31, 2026 0.65% $1.20 135.96%
Morgan Stanley - Brokerage Accounts 211.11K Mar 31, 2026 0.61% $0.00 -12.94%
Vanguard Portfolio Management, LLC 168.47K Mar 31, 2026 0.49% $0.00 0.00%
Citadel Advisors Llc 153.61K Mar 31, 2026 0.44% $0.00 -23.10%
Northern Trust Corp 152.12K Mar 31, 2026 0.44% $0.00 35.71%
Lion Point Capital, LP 112.43K Mar 31, 2026 0.32% $4.13 0.00%
Petersen Flynn & Dinsmore Inc 105.00K Mar 31, 2026 0.30% $0.06 0.00%
Gendell Jeffrey L 83.02K Mar 31, 2026 0.24% $0.01 -40.51%
Bridgeway Capital Management, LLC 83.01K Mar 31, 2026 0.24% $0.01 0.00%
Charles Schwab Investment Management Inc 63.54K Mar 31, 2026 0.18% $0.00 10.98%

Shares Statistics

Shares Outstanding: 34.74M
Shares Float: 16.83M
% Insiders: 1,446.00%
% Institutions: 5,429.00%
Short % Float: 1.63%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 873.03K 2.51% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 634.89K 1.83% ▲ 0.93% May 29, 2026
3 Fidelity Small Cap Index 283.19K 0.82% ▲ 25.46% Mar 31, 2026
4 iShares Russell 2000 Value ETF 184.14K 0.53% ▲ 0.00% May 29, 2026
5 Vanguard Russell 2000 ETF 146.40K 0.42% ▲ 2.15% Apr 30, 2026
6 Russell 2000 Equity Index Fund B 144.30K 0.42% ▼ 0.05% Dec 31, 2025
7 State St Russell Sm/Mid Cp® Indx SL Cl I 125.70K 0.36% ▲ 0.00% May 31, 2026
8 Bridgeway Ultra-Small Company 83.01K 0.24% ▲ 0.00% Mar 31, 2026
9 iShares Micro-Cap ETF 73.92K 0.21% ▲ 0.00% May 29, 2026
10 State St Russell Sm Cap® Idx SL Cl I 72.80K 0.21% ▲ 0.00% May 31, 2026

Valuation Metrics

Enterprise Value: $318.24M
Trailing P/E: 0.00
Forward P/E: 41.32

Financial Highlights

Market Cap: $364.39M
EBITDA: $-5.49M
PEG Ratio: $1.47
Book Value: $1.09
Earnings/Share: $-0.29
Profit Margin: -16.42%
Operating Margin: -0.79%
ROA (TTM): -5.91%
ROE (TTM): -52.68%
Revenue (TTM): $51.00M
Revenue/Share (TTM): $1.69
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 72.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.34x 0.00x 0.50x -3.05x 0.00x
2024-12-31 6.38x -3.29x 1.13x 0.61x 4.03x
2023-12-31 3.56x -2.66x 1.43x -3.85x -2.50x
2022-12-31 5.80x -9.69x 1.10x -23.25x -1.10x
2021-12-31 13.54x 0.32x 0.30x -136.69x -0.29x
2020-12-31 13.39x 0.00x 0.07x -1,987.22x 0.00x
2019-12-31 6.11x 0.00x 0.16x N/A 0.00x
2018-12-31 14.02x 0.00x 0.07x N/A 0.00x
2017-12-31 17.28x 0.01x 0.06x N/A -1.76x
2016-12-31 9.88x 0.01x 0.10x N/A 0.40x
2015-12-31 2.16x 0.15x 0.46x N/A -0.14x
2014-12-31 1.35x 2.15x 0.74x -1,438.50x -0.64x
2013-12-31 0.55x -1.97x 1.83x N/A 1.60x
2012-12-31 0.32x 0.00x 3.10x N/A 0.00x
2011-12-31 0.98x 0.00x 1.02x N/A 0.00x
2010-12-31 0.55x 0.00x 1.82x N/A 0.00x
2009-12-31 1.98x 0.00x 0.51x N/A 0.00x
2008-12-31 2.32x 0.00x 0.50x N/A 0.00x
2007-12-31 6.89x 0.00x 0.18x N/A 0.00x
2006-12-31 1.26x 0.00x 0.54x -6,354.33x 0.00x
2005-12-31 5.03x 0.00x 0.29x -1,667.82x 0.00x
2003-12-31 14.69x 0.00x 0.21x -21.22x 0.00x
2002-12-31 3.06x 0.08x 0.40x N/A -0.23x
2001-12-31 8.91x 0.00x 0.11x N/A 0.00x
2000-12-31 18.92x 0.00x 0.06x N/A -0.01x
1999-12-31 0.91x 1.24x 0.93x N/A -0.02x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FENC.US!